» Authors » Matthias Floeth

Matthias Floeth

Explore the profile of Matthias Floeth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 24
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ronnacker J, Grau M, Klasmeier M, Klesse C, Baldauf H, Abert S, et al.
Blood . 2025 Jan; PMID: 39813679
Apolipoprotein E (APOE) has multiple functions in metabolism and immunoregulation. Its common germline variants APOE2, APOE3 and APOE4 give rise to three functionally distinct gene products. Previous studies reported yin-yang...
2.
Stelljes M, Sockel K, Floeth M, Schetelig J, Bornhauser M, Reicherts C, et al.
Bone Marrow Transplant . 2024 Nov; 60(1):103-106. PMID: 39500997
No abstract available.
3.
Ronnacker J, Urbahn M, Reicherts C, Kolloch L, Berning P, Sandmann S, et al.
Br J Haematol . 2024 Jun; 205(1):280-290. PMID: 38831752
For patients with relapsed or refractory AML, sequential conditioning prior to allogeneic stem cell transplantation (alloSCT) is an established and potentially curative treatment option. Early response to treatment during conditioning...
4.
Berning P, Kolloch L, Reicherts C, Call S, Marx J, Floeth M, et al.
Bone Marrow Transplant . 2024 May; 59(8):1097-1106. PMID: 38702400
Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a standard treatment for patients with AML and MDS. The combination of fractionated total body irradiation(8GyTBI/Flu) with fludarabine is an established conditioning regimen,...
5.
Rauwolf K, Floeth M, Kerl K, Schaumburg F, Groll A
Clin Microbiol Infect . 2020 Oct; 27(3):378-388. PMID: 33065238
Background: Toxoplasmosis is a rare but highly lethal opportunistic infection after allogeneic haematopoietic cell transplantation (HCT). Successful management depends on screening, early recognition and effective treatment. Objectives: To review the...
6.
Floeth M, Elges S, Gerss J, Schwoppe C, Kessler T, Herold T, et al.
Br J Haematol . 2020 Jun; 192(3):494-503. PMID: 32511755
The low-density lipoprotein receptor (LDLR) is a membrane receptor that mediates the endocytosis of low-density lipoprotein (LDL). Uptake of LDL has been proposed to contribute to chemotherapy resistance of acute...